to fully acquire

LONDON: Haleon plc has entered into an agreement to acquire the remaining 12% equity interest in its Chinese over-the-counter (OTC) joint venture, Tianjin TSKF Pharmaceutical Co., Ltd., from partner Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, the company announced Tuesday….